Synovial sarcoma is a soft tissue malignancy driven by the SS18-SSX fusion oncoprotein. In Nature Medicine, Jerby-Arnon et al. present a single-cell dataset for synovial sarcoma that reveals a novel 'core oncogenic program' driven by SS18-SSX, with implications for treatment strategies based on epigenetics, cell-cycle control, and immune augmentation.Medicine, Faculty ofReviewedFacultyGraduat
Human synovial sarcomas are aggressive soft tissue tumors with relatively high rates of recurrences ...
Like many sarcomas, synovial sarcoma is driven by a characteristic oncogenic transcription factor fu...
Recently we demonstrated that the synovial sarcoma specific fusion gene SS18-SSX is crucial for cycl...
Synovial sarcoma is a soft tissue malignancy driven by the SS18-SSX fusion oncoprotein. In Nature M...
© 2021, The Author(s), under exclusive licence to Springer Nature America, Inc. Synovial sarcoma (Sy...
Synovial sarcoma (SyS) is an aggressive neoplasm driven by the SS18-SSX fusion, and is characterized...
The prevalence and specificity of unique fusion oncogenes are high in a number of soft tis-sue sarco...
Synovial sarcoma is a rare but mostly aggressive soft tissue tumor that mainly affects children and ...
Synovial sarcoma (SS), an aggressive type of soft tissue tumor, occurs mostly in adolescents and you...
Synovial sarcoma is a highly invasive soft tissue malignancy of young people, for which current trea...
Synovial sarcoma is a soft tissue tumor defined by the presence of t(X;18)(p11.2;q11.2), fusing the ...
Synovial Sarcoma (SS) is a soft tissue neoplasm characterized by the translocation [t(X;18)(p11;q11)...
Synovial sarcoma is a highly aggressive soft tissue malignancy that often affects adolescents and yo...
Human synovial sarcomas are aggressive soft tissue tumors with relatively high rates of recurrences ...
<div><p>The prevalence and specificity of unique fusion oncogenes are high in a number of soft tissu...
Human synovial sarcomas are aggressive soft tissue tumors with relatively high rates of recurrences ...
Like many sarcomas, synovial sarcoma is driven by a characteristic oncogenic transcription factor fu...
Recently we demonstrated that the synovial sarcoma specific fusion gene SS18-SSX is crucial for cycl...
Synovial sarcoma is a soft tissue malignancy driven by the SS18-SSX fusion oncoprotein. In Nature M...
© 2021, The Author(s), under exclusive licence to Springer Nature America, Inc. Synovial sarcoma (Sy...
Synovial sarcoma (SyS) is an aggressive neoplasm driven by the SS18-SSX fusion, and is characterized...
The prevalence and specificity of unique fusion oncogenes are high in a number of soft tis-sue sarco...
Synovial sarcoma is a rare but mostly aggressive soft tissue tumor that mainly affects children and ...
Synovial sarcoma (SS), an aggressive type of soft tissue tumor, occurs mostly in adolescents and you...
Synovial sarcoma is a highly invasive soft tissue malignancy of young people, for which current trea...
Synovial sarcoma is a soft tissue tumor defined by the presence of t(X;18)(p11.2;q11.2), fusing the ...
Synovial Sarcoma (SS) is a soft tissue neoplasm characterized by the translocation [t(X;18)(p11;q11)...
Synovial sarcoma is a highly aggressive soft tissue malignancy that often affects adolescents and yo...
Human synovial sarcomas are aggressive soft tissue tumors with relatively high rates of recurrences ...
<div><p>The prevalence and specificity of unique fusion oncogenes are high in a number of soft tissu...
Human synovial sarcomas are aggressive soft tissue tumors with relatively high rates of recurrences ...
Like many sarcomas, synovial sarcoma is driven by a characteristic oncogenic transcription factor fu...
Recently we demonstrated that the synovial sarcoma specific fusion gene SS18-SSX is crucial for cycl...
DOI
Add to ORKG